keyword
https://read.qxmd.com/read/38735258/clinical-evidence-for-the-prognostic-impact-of-metformin-in-cancer-patients-treated-with-immune-checkpoint-inhibitors
#21
JOURNAL ARTICLE
Jinhai Shen, Xinqi Ye, Hui Hou, Yun Wang
BACKGROUND: Preclinical studies suggest that metformin might enhance the efficacy of immune checkpoint inhibitors (ICIs) and potentially influence the prognoses of cancer patients undergoing ICIs treatment. This study endeavors to assess the prognostic significance of metformin in cancer patients undergoing ICIs therapy, aiming to furnish evidence-based insights for clinical practice. METHODS: A thorough literature search was conducted across electronic databases to encompass all potential records published before November 20th, 2023...
May 11, 2024: International Immunopharmacology
https://read.qxmd.com/read/38735257/heterogeneity-of-myeloid-cells-in-common-cancers-single-cell-insights-and-targeting-strategies
#22
REVIEW
Zhi-Qian Jing, Zhi-Qi Luo, Si-Rui Chen, Zhi-Jun Sun
Tumor microenvironment (TME), is characterized by a complex and heterogenous composition involving a substantial population of immune cells. Myeloid cells comprising over half of the solid tumor mass, are undoubtedly one of the most prominent cell populations associated with tumors. Studies have unambiguously established that myeloid cells play a key role in tumor development, including immune suppression, pro-inflammation, promote tumor metastasis and angiogenesis, for example, tumor-associated macrophages promote tumor progression in a variety of common tumors, including lung cancer, through direct or indirect interactions with the TME...
May 11, 2024: International Immunopharmacology
https://read.qxmd.com/read/38735256/advances-of-ultrasound-in-tumor-immunotherapy
#23
REVIEW
Jing Lin, Yuwei Wu, Guangde Liu, Rui Cui, Youhua Xu
Immunotherapy has become a revolutionary method for treating tumors, offering new hope to cancer patients worldwide. Immunotherapy strategies such as checkpoint inhibitors, chimeric antigen receptor T-cell (CAR-T) therapy, and cancer vaccines have shown significant potential in clinical trials. Despite the promising results, there are still limitations that impede the overall effectiveness of immunotherapy; the response to immunotherapy is uneven, the response rate of patients is still low, and systemic immune toxicity accompanied with tumor cell immune evasion is common...
May 11, 2024: International Immunopharmacology
https://read.qxmd.com/read/38735178/the-safety-and-efficacy-of-tumor-necrosis-factor-alpha-inhibitor-on-pregnancy-outcomes-in-patients-with-unexplained-recurrent-miscarriage
#24
JOURNAL ARTICLE
Fangxiang Mu, Chen Wang, Lin Liu, Xianghui Zeng, Fang Wang
OBJECTIVES: Although tumor necrosis factor-alpha inhibitor (TNFi) treatment may improve pregnancy outcomes in unexplained recurrent miscarriage (URM) patients, evidence for its efficacy and safety is still insufficient. The goal of this study was to evaluate the efficacy and safety of TNFi on pregnancy outcomes in patients with URM. METHODS: This retrospective study was conducted at a single institution in China, involving 121 patients treated with TNFi for URM from 2019 to 2022...
May 9, 2024: Immunobiology
https://read.qxmd.com/read/38734651/sublingual-immunotherapy-for-allergy-to-shrimp-the-nine-year-clinical-experience-of-a-midwest-allergy-immunology-practice
#25
JOURNAL ARTICLE
Lydia M Theodoropoulou, Niamh A Cullen
BACKGROUND: Diet restrictions and fear of adverse reactions put a significant burden on the nutrition, growth and life style of children and adults with food allergies. While various disease-modifying options are pursued, there are so far no published clinical data on immunotherapy for crustaceans. The efficacy and safety of desensitization to crustaceans by means of sublingual immunotherapy is assessed for the first time in this study with a view of validating it as a clinical-practice modality...
May 11, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38734566/corrigendum-to-chondroprotective-effects-of-apolipoprotein-d-in-knee-osteoarthritis-mice-through-the-pi3k-akt-mtor-signaling-pathway-int-immunopharmacol-133-2024-112005
#26
Gang Zhang, Chao Huang, Ren Wang, Jiangrong Guo, Yong Qin, Songcen Lv
No abstract text is available yet for this article.
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733829/magnolin-inhibits-intestinal-epithelial-cell-apoptosis-alleviating-crohn-s-disease-like-colitis-by-suppressing-the-pi3k-akt-signalling-pathway
#27
JOURNAL ARTICLE
Min Zhang, Xue Song, Shengbao Liu, Nuo Zhang, Ming Yang, Pengcheng Gao, Zhijun Geng, Lugen Zuo, Xiaofeng Zhang, Lian Wang, Yueyue Wang, Jing Li, Jianguo Hu
BACKGROUND AND AIMS: Previous reports have shown that preventing excessive intestinal epithelial cell (IEC) apoptosis is a crucial approach for protecting the intestinal barrier in patients with Crohn's disease (CD). Magnolin (MGL) has various biological activities, including antiapoptotic activities, but its role in CD has largely not been determined. This study investigated how MGL impacts CD-like colitis and the underlying mechanism involved. METHODS: Mice were treated with TNBS to establish a disease model, and these mice were used to assess the therapeutic effects of MGL on CD-like colitis...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733828/differences-in-the-expression-of-long-noncoding-rnas-in-peripheral-blood-mononuclear-cells-indicate-potential-biomarkers-for-rheumatoid-arthritis
#28
JOURNAL ARTICLE
Hong-Miao Li, Li-Jun Wang, Yi-Ping Wang, Xiao-Mei Li, Hai-Feng Pan
OBJECTIVE: Long noncoding RNAs (lncRNAs) play an increasingly important role in various autoimmune diseases. We aimed to characterize the expression profiles of lncRNAs in peripheral blood mononuclear cells (PBMCs) from RA patients and to assess the potential of these lncRNAs as RA biomarkers. METHODS: Whole-transcriptome sequencing was used to establish a lncRNA expression profile. A total of 155 RA patients, 145 healthy controls, 59 systemic lupus erythematosus (SLE) patients and 59 primary Sjögren's syndrome (pSS) patients were recruited for this study...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733827/the-macrophage-migration-inhibitory-factor-is-a-vital-player-in-pan-cancer-by-functioning-as-a-m0-macrophage-biomarker
#29
JOURNAL ARTICLE
Yuting Pu, Guifang Yang, Yang Zhou, Xiaogao Pan, Tuo Guo, Xiangping Chai
BACKGROUND: The role of the macrophage migration inhibitory factor (MIF) has recently attracted considerable attention in cancer research; nonetheless, the insights provided by current investigations remain constrained. Our main objective was to investigate its role and the latent mechanisms within the pan-cancer realm. METHODS: We used comprehensive pan-cancer bulk sequencing data and online network tools to investigate the association between MIF expression and patient prognosis, genomic instability, cancer cell stemness, DNA damage repair, and immune infiltration...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733826/a-novel-senescence-based-prognostic-model-unveils-tumor-interactions-and-drug-resistance-in-colorectal-cancer
#30
JOURNAL ARTICLE
Yanzhe Yue, Xiangjian She, Wenbo Ding, Shuyu Chen, Qianni Xiao, Bei Pan, Linpeng Zhou, Yujuan Yin, Youyue Li, Shukui Wang, Mu Xu
BACKGROUND: In China, CRC incidence is escalating. The main hurdles are heterogeneity and drug resistance. This research delves into cellular senescence in CRC, aiming to devise a prognostic model and pinpoint mechanisms impacting drug resistance. METHODS: Mendelian randomization (MR) analysis confirmed the association between CRC and cellular aging. The Cancer Genome Atlas (TCGA)-CRC data served as the training set, with GSE38832 and GSE39582 as validation sets...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733825/silencing-bmal1-promotes-m1-m2-polarization-through-the-ldha-lactate-axis-to-promote-gbm-sensitivity-to-bevacizumab
#31
JOURNAL ARTICLE
Fan Wang, Wenjun Liao, Caiyan Li, Ling Zhu
OBJECTIVE: Glioblastoma (GBM) has poor clinical prognosis due to limited treatment options. In addition, the current treatment regimens for GBM may only slightly prolong patient survival. The aim of this study was to assess the role of BMAL1 in the immune microenvironment and drug resistance of GBM. METHODS: GBM cell lines with stable BMAL1 knockdown or LDHA overexpression were constructed, and functionally characterized by the CCK8, EdU incorporation, and transwell assays...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733824/cortistatin-protects-against-septic-cardiomyopathy-by-inhibiting-cardiomyocyte-pyroptosis-through-the-sstr2-ampk-nlrp3-pathway
#32
JOURNAL ARTICLE
Fengqi Duan, Li Li, Sijun Liu, Jun Tao, Yang Gu, Huangjing Li, Xiaoling Yi, Jianfeng Gong, Daiting You, Zejiang Feng, Tao Yu, Hongmei Tan
BACKGROUND: Although the pathophysiological mechanism of septic cardiomyopathy has been continuously discovered, it is still a lack of effective treatment method. Cortistatin (CST), a neuroendocrine polypeptide of the somatostatin family, has emerged as a novel cardiovascular-protective peptide, but the specific mechanism has not been elucidated. PURPOSE: The aim of our study is to explore the role of CST in cardiomyocytes pyroptosis and myocardial injury in sepsis and whether CST inhibits cardiomyocytes pyroptosis through specific binding with somastatin receptor 2 (SSTR2) and activating AMPK/Drp1 signaling pathway...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733823/interferon-induced-polarization-of-m1-macrophages-mediates-antiviral-activity-against-the-hepatitis-b-virus-via-the-hepcidin-ferroportin-axis
#33
JOURNAL ARTICLE
Qian Liu, Jianfei Li, Qiyin Zong, Zhi Duan, Futing Liu, Wanlu Duan, Mengqi Ruan, Hao Zhang, Yan Liu, Qiang Zhou, Qin Wang
BACKGROUNDS & AIMS: Given its ability to inhibit HBV replication, Interferon alpha (IFN-α) treatment has been confirmed to be effective in managing Chronic Hepatitis B (CHB). However, its underlying mechanisms are incompletely understood. METHODS: Herein, we investigated the antiviral properties of IFN-α by introducing IFN-α expression plasmids into a well-established HBV Hydrodynamic Injection (HDI) mouse model and examined the impact of IFN-α or hepcidin treatment on macrophages derived from THP-1 cells...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733822/tgfbi-a-novel-therapeutic-target-for-cancer
#34
REVIEW
Huimei Huang, Qinglai Tang, Shisheng Li, Yuexiang Qin, Gangcai Zhu
TGFBI, an extracellular matrix protein induced by transforming growth factor β, has been found to exhibit aberrant expression in various types of cancer. TGFBI plays a crucial role in tumor cell proliferation, angiogenesis, and apoptosis. It also facilitates invasion and metastasis in various types of cancer, including colon, head and neck squamous, renal, and prostate cancers. TGFBI, a prominent p-EMT marker, strongly correlates with lymph node metastasis. TGFBI demonstrates immunosuppressive effects within the tumor immune microenvironment...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733821/asiaticoside-promoted-ferroptosis-and-suppressed-immune-escape-in-gastric-cancer-cells-by-downregulating-the-wnt-%C3%AE-catenin-pathway
#35
JOURNAL ARTICLE
Chenmin Ye, Zhichao Yao, Yaoyao Wang, Chao Zhang
BACKGROUND: Our previous study has revealed that asiaticoside (AC) promotes endoplasmic reticulum stress and antagonizes proliferation and migration of gastric cancer (GC) via miR-635/HMGA1 axis. However, the effect and mechanism of AC on other progressions of GC, such as ferroptosis and immune escape, are still unknown. METHODS: AGS and HGC27 cells were incubated with 1, 2 and 4 μM of AC for 24 h. Mice xenografted with AGS cells were intragastrically injected with AC...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733820/a-study-on-combination-of-non-ablative-local-rfa-with-pd-1-and-angiogenesis-blocking-to-prolong-survival-through-improvement-of-immune-microenvironment-in-advanced-hepatocellular-carcinoma
#36
JOURNAL ARTICLE
Tianlin Xiao, Sheng Hu, Shuang Dong, Qian Cai, Wei Gong, Yang Zhang, Cheng Long, Xiaoyu Li
Radiofrequency ablation (RFA), an effective local treatment method for early-stage Hepatocellular Carcinoma (HCC), combined with PD-1 blocking and anti-angiogenic therapy is being extensively explored in advanced HCC, however, the definite results and underlying mechanisms still remain to be elucidated. Therefore, whether non-ablative RFA-based combined therapy can play a synergistic anti-tumor effect through improving tumor immune microenvironment was investigated by us in HCC mouse models. Our results showed that non-ablative RFA could regulate multilayered immunity, such as inducing immunogenic death of tumor cells, upregulating the secretion of inflammatory cytokines, mainly IFN-γ, TNF-α, and IL-10, and subsequently promoting the infiltration of CD8 + T cells...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733819/a-prospective-cohort-based-artificial-intelligence-evaluation-system-for-the-protective-efficacy-and-immune-response-of-sars-cov-2-inactivated-vaccines
#37
JOURNAL ARTICLE
Jin Zhang, Yuan Meng, Mei Yang, Wudi Hao, Jianhua Liu, Lina Wu, Xiaojun Yu, Yue Zhang, Baoxu Lin, Chonghong Xie, Lili Ge, Zhijie Zhang, Weiwei Tong, Qing Chang, Yong Liu, Yixiao Zhang, Xiaosong Qin
BACKGROUND: Novel coronaviruses constitute a significant health threat, prompting the adoption of vaccination as the primary preventive measure. However, current evaluations of immune response and vaccine efficacy are deemed inadequate. OBJECTIVES: The study sought to explore the evolving dynamics of immune response at various vaccination time points and during breakthrough infections. It aimed to elucidate the synergistic effects of epidemiological factors, humoral immunity, and cellular immunity...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733818/s100a16-is-a-potential-target-for-reshaping-the-tumor-microenvironment-in-the-hypoxic-context-of-liver-cancer
#38
JOURNAL ARTICLE
Dashuai Yang, Fangrui Zhao, Yu Zhou, Yanbing Zhang, Jie Shen, Bin Yu, Kailiang Zhao, Youming Ding
BACKGROUND: The research on the S100 family has garnered significant attention; however, there remains a dearth of understanding regarding the precise role of S100A16 in the tumor microenvironment of liver cancer. METHOD: Comprehensive analysis was conducted on the expression of S100A16 in tumor tissues and its correlation with hypoxia genes. Furthermore, an investigation was carried out to examine the association between S100A16 and infiltration of immune cells in tumors as well as immunotherapy...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733817/current-status-of-bispecific-antibodies-and-car-t-therapies-in-multiple-myeloma
#39
REVIEW
Wojciech Szlasa, Jarosław Dybko
Multiple myeloma (MM), a malignancy of plasma cells, is an incurable disease that is characterized by the neoplastic proliferation of plasma cells leading to extensive skeletal destruction. This includes osteolytic lesions, osteopenia, and pathologic fractures. MM is clinically manifested through bone pain, renal insufficiency, hypercalcemia, anemia, and recurrent infections. Its prevalence and the need for effective treatment underscore the importance of this research. Recent advancements in MM therapy have been significant, particularly with the integration of daratumumab into first-line treatments...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38733699/enhancing-antitumor-response-by-efficiently-generating-large-scale-tcr-t-cells-targeting-a-single-epitope-across-multiple-cancer-antigens
#40
JOURNAL ARTICLE
Obed Boadi Amissah, Rajesh Basnet, Wenfang Chen, Jean de Dieu Habimana, Belinda Edwina Baiden, Osei Asibey Owusu, Babangida Jabir Saeed, Zhiyuan Li
The need to contrive interventions to curb the rise in cancer incidence and mortality is critical for improving patients' prognoses. Adoptive cell therapy is challenged with quality large-scale production, heightening its production cost. Several cancer types have been associated with the expression of highly-immunogenic CTAG1 and CTAG2 antigens, which share common epitopes. Targeting two antigens on the same cancer could improve the antitumor response of TCR-T cells. In this study, we exploited an efficient way to generate large-fold quality TCR-T cells and also demonstrated that the common epitopes of CTAG1 and CTAG2 antigens provide an avenue for improved cancer-killing via dual-antigen-epitope targeting...
May 10, 2024: Cellular Immunology
keyword
keyword
115750
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.